Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them

US8350055B2 · kind B2 · utility

Assignee

• Abbott GmbH & Co. KG · DE

Inventors

• Thorsten Oost · Biberach an der Riß, DE
• Wilfried Hornberger · Wiesbaden, DE
• Hervé Geneste · Schifferstadt, DE
• Daryl Sauer · Pleasant Prairie, US
• Wolfgang Wernet · Ludwigshafen, DE
• Liliane Unger · Ludwigshafen, DE
• Wilfried Lubisch · Mannheim, DE

Key dates

• Filing date: Jul 20, 2010
• Grant date: Jan 8, 2013
• Expiry date: Jul 20, 2030

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D513/04
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to novel 1,3-dihydroindol-2-one (oxindole) derivatives of the formula (I) in which A, R3, R4, R5, R6, and R7 are defined according to claim 1, and to medicaments containing them for the treatment of diseases. In particular, the novel oxindole derivatives can be used for the control and/or prophylaxis of various vasopressin-dependent or oxytocin-dependent diseases.